Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar FedeTech (< 20) Submitted: 2/14/2011 7:44:39 PM : Outperform Start Price: $0.51 BPAX Score: -6.45

Soon $3 or more. Be carefull with bashers! Great product. And safe! Also buy-out candidate.

Featured Broker Partners


Advertisement